A 100% French nasal vaccine against COVID-19 yields positive pre clinical results For a year now, the BioMAP research team, from the lnfectiology and Public Health (ISP) jointresearch unit run by INRAE and the Université de Tours, has been involved with support of manycollaborators, in the development of a 100% French nasal vaccine against the SARS-CoV-2 virus. Thisproject is well in line with the commitment to partnership research promoted by the InstitutCarnot's France Futur Élevage programme, of which INRAE and the university are co-directors.
